Clinical analysis of drug treatment of advanced gastric cancer.
HE Mei-wen,YU Ding,BAI Zhi-Jun
DOI: https://doi.org/10.3969/j.issn.1671-4695.2010.13.005
2010-01-01
Abstract:Objective This paper discusses the treatment of advanced gastric cancer drug efficacy and response.Methods 19 patients were diagnosed by pathology or cytology of advanced gastric cancer,are complex medical treatment of people.All patients had an objective evaluation.With irinotecan CPT-11 60 mg/m2,intravenous drip1,8,15 d;oxaliplatin(LOHP) 130 mg/m2,intravenous drip 1 d,28 d as a cycle,2 cycles of continuous use Evaluation of efficacy and adverse reactions.Results 19 patients completed 2 cycles of chemotherapy,received 42 cycles of chemotherapy,all patients could be evaluated the efficacy and adverse reactions.No case of CR,PR 7 cases(36.8%),NC 4 cases(21.1%),PD 8 cases(42.6%),the effective rate was 36.8%,the median survival of 8.6 months;main adverse events were neutropenia,diarrhea,nausea,vomiting,peripheral neurotoxicity,Ⅲ-IV degree low incidence of adverse reactions,neutropenia 15.0%,diarrhea 4.2%.Conclusion Patients with advanced gastric cancer have the exact effect of drug therapy,adverse reactions,and well tolerated.